Yüklüyor......
TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy
Targeted T cells are emerging as effective non-toxic therapies for cancer. Multiple elements, however, contribute to the overall pathogenesis of cancer through both distinct and redundant mechanisms. Hence, targeting multiple cancer-specific markers simultaneously could result in better therapeutic...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Nature Publishing Group
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3731887/ https://ncbi.nlm.nih.gov/pubmed/23839099 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mtna.2013.32 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|